This message was sent to ##Email##
|
|
|
Medical News Today
A new study, published in the Journal of Medicinal Chemistry, offers the first proof that a new synthetic form of the antibiotic teixobactin can neutralize drug-resistant bacteria. The Centers for Disease Control and Prevention say that antibiotic resistance is "one of the world's most pressing public health problems."
READ MORE
HealthDay News via Infectious Disease Advisor
The burden of two of the most common symptoms in patients living with HIV — fatigue and muscle aches/joint pains — is higher in women, according to a study published in Menopause.
Rebecca Schnall, Ph.D., MPH, RN, from Columbia University in New York City, and colleagues studied the effect of menopause on sex differences in HIV symptom burden using survey data from 1,342 respondents to an online survey and a follow-up, online survey of menstrual bleeding patterns (inferred menopause) in eligible females.
READ MORE
DARK Daily
Microhospitals are opening nationwide, including in such innovative states as Texas, Colorado, Nevada and Arizona. In addition to being open 24/7 and mostly located in high-density areas, these scaled down hospitals feature the most critical aspects of full-size hospitals — medical laboratories, emergency departments, pharmacies and imaging centers.
READ MORE
Promoted by
|
|
|
 |
North Carolina State University via Infection Control Today
Using a mouse model, researchers from North Carolina State University have found that antibiotic use creates a "banquet" for Clostridium difficile by altering the native gut bacteria that would normally compete with C-diff for nutrients. The findings could lead to the development of probiotics and other strategies for preventing C-diff infection.
READ MORE
|
|
Northwestern University via Medical Xpress
Northwestern Medicine scientists have discovered how the process of DNA methylation regulates the development of spinal cord motor neurons, according to a study published in the journal Cell Stem Cell.
DNA methylation, an epigenetic mechanism that determines whether or not a gene is expressed, guides stem cells as they transform from blank slates into specialized cells.
READ MORE
 |
|
The LIAISON® Treponema assay is your solution for automating syphilis testing. Improve sensitivity and specificity over RPR screening using our fully-automated LIAISON® XL platform. The LIAISON® Treponema assay detects both IgG and IgM antibody response to T. pallidum infections. Visit www.diasorin.com for more information.
|
|
HealthDay News
Though fewer Americans are now dying from infectious diseases, great disparities persist across the country, a new study finds.
Between 1980 and 2014, just over 4 million Americans died from infectious diseases. But while overall infectious disease deaths have dropped almost 19 percent, death rates differed widely by county.
READ MORE
Outbreak News Today
A team of researchers led by Brown University infectious disease experts and engineers has identified a new class of antibiotics that could one day help combat the alarming emergence of drug-resistant "superbugs." Eleftherios Mylonakis, a professor of infectious diseases at Brown's Warren Alpert Medical School and chief of infectious diseases at Rhode Island Hospital and the Miriam Hospital, led a multidisciplinary team of researchers searching for drugs to target bacteria that have developed a resistance to conventional antibiotics.
READ MORE
|
|
UT Southwestern Medical Center via Lab Manager
Scientists have found a genetic trigger that may improve the brain's ability to heal from a range of debilitating conditions, from strokes to concussions and spinal cord injuries.
A new study in mice from UT Southwestern's O'Donnell Brain Institute shows that turning on a gene inside cells called astrocytes results in a smaller scar and — potentially — a more effective recovery from injury.
READ MORE
|
To find out how to feature your company in the ASCLS eNewsletter and other advertising opportunities, Contact James DeBois at 469-420-2618.
MORE
|
|
|
|
SeraSub® is a synthetic serum for use as a component in preparing standards and controls for in-vitro diagnostic tests. Learn more
|
|
|
|
Georgia State University via ScienceDaily
An organic chemical compound shows effective anti-viral activity against Ebola virus and several other viruses, according to a study led by Georgia State University.
The researchers found benzoquinoline inhibited the ability of Ebola virus to multiply and reproduce in cell culture. The findings are published in the journal Antiviral Research.
READ MORE
|
|
|
 7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063
|